Search results
Louisiana is first state to classify abortion drugs as controlled dangerous substances after GOP...
KOAM· 1 day ago“Requiring an abortion inducing drug to be obtained with a prescription and criminalizing the use of an abortion drug on an unsuspecting mother is nothing ...
Medicare is negotiating drug prices. Here's why that matters
AOL· 1 day agoFor the first time, Medicare is now negotiating the prices of some prescription drugs. It's a move with overwhelming public support, and a provision most Americans don't know exists. Medicare ...
This overlooked obesity-drug stock has 80% upside, JPMorgan says
Business Insider via Yahoo Finance· 4 days agoThe bank initiated coverage of the near-$2 billion biotech company with an "Overweight" rating and...
The #1 Mistake People Make While on Weight Loss Drugs Like Ozempic, According to an Obesity Doctor
Parade via Yahoo News· 5 days agoOzempic pen Prescriptions for Ozempic—a drug used to manage type 2 diabetes and that many also take...
Durham public company raises $10M to accelerate sales - Triangle Business Journal
The Business Journals· 1 day agoPolarean Imagining has raised $10 million as it ramps up commercialization of its drug device...
Patent reform could be the next big move to help bring down drug prices
Axios· 3 days agoWhy it matters: There's widespread agreement that pharmaceutical companies have gamed the system...
New Pain Drug Could Be Big For Vertex Stock As Shares Score Breakout
Investor's Business Daily· 1 day agoBut what really got investors talking was Vertex's new pain drug, VX-548. Vertex hopes this drug...
Hims & Hers Selling GLP-1 Weight Loss Drugs Like Wegovy for 85% Less: What to Know
Healthline via AOL· 3 days agoTelehealth company Hims & Hers announced they will begin selling off-brand GLP-1 drugs similar to...
Move Over Ozempic! 3 New GLP-1 Drugs and Products Coming Soon.
InvestorPlace· 3 days agoFor investors looking at companies providing GLP-1 drugs, there are certainly plenty of factors to...
Down 72%. Is Ginkgo Bioworks a Buy on the Dip?
Motley Fool via Yahoo Finance· 14 hours agoIt has been difficult to be a shareholder of Ginkgo Bioworks (NYSE: DNA) over the past year. The stock has collapsed about 72% from its peak last summer....